The administration of milk fermented by the probiotic Lactobacillus casei CRL 431 exerts an immunomodulatory effect against a breast tumour in a mouse model

Immunobiology

Volumn 219, Issue 6, 2014, Pages 457-464

  Aragón, Félix ^a   Carino, Silvia ^b   Perdigón, Gabriela ^a,b   De Moreno de LeBlanc, Alejandra ^a  

^a CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^b UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Angiogenesis; Breast cancer; Immune response; Mouse model; Probiotic

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; F4/80 ANTIGEN; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 6; LYMPHOCYTE ANTIGEN; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DIFFERENTIATION ANTIGEN; IL10 PROTEIN, MOUSE; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER TISSUE; CONTROLLED STUDY; FEMALE; FERMENTATION; IMMUNOMODULATION; LACTOBACILLUS CASEI; LACTOBACILLUS CASEI CRL 431; MAMMARY GLAND; MICROVASCULATURE; MILK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TUMOR DIAGNOSIS; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL PROLIFERATION; CYTOLOGY; DISEASE MODEL; HUMAN; IMMUNOLOGY; MAMMARY NEOPLASMS, ANIMAL; METABOLISM; MICROBIOLOGY; PATHOLOGY; UDDER;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; FEMALE; FERMENTATION; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-10; INTERLEUKIN-6; LACTOBACILLUS CASEI; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED BALB C; MILK; PROBIOTICS;

EID: 84899483285     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2014.02.005     Document Type: Article

References (41)

1. American Cancer Society Cancer Facts and Figures 2013 2013, American Cancer Society, Atlanta.
2. Biffi A., Coradini D., Larsen R., Riva L., Di Fronzo G. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer 1997, 28:93-99.
3. Brandtzaeg P., Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol. 2004, 25:570-577.
4. de Moreno de Leblanc A., Perdigon G. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc. Nutr. Soc. 2010, 69:421-428.
5. de Moreno de LeBlanc A., Matar C., LeBlanc N., Perdigon G. Effects of milk fermented by Lactobacillus helveticus R389 on a murine breast cancer model. Breast Cancer Res. 2005, 7:R477-R486.
6. de Moreno de LeBlanc A., Matar C., Theriault C., Perdigon G. Effects of milk fermented by Lactobacillus helveticus R389 on immune cells associated to mammary glands in normal and a breast cancer model. Immunobiology 2005, 210:349-358.
7. de Moreno de LeBlanc A., Maldonado Galdeano C., Chaves S., Perdigón G. Oral administration of Lactobacillus casei CRL 431 increases immunity in bronchus and mammary glands. Eur. J. Inflamm. 2005, 2:23-28.
8. de Moreno de LeBlanc A., Matar C., Farnworth E., Perdigon G. Study of cytokines involved in the prevention of a murine experimental breast cancer by kefir. Cytokine 2006, 34:1-8.
9. de Visser K.E., Coussens L.M. The inflammatory tumor microenvironment and its impact on cancer development. Contrib. Microbiol. 2006, 13:118-137.
10. Divisi D., Di Tommaso S., Salvemini S., Garramone M., Crisci R. Diet and cancer. Acta Biomed. 2006, 77:118-123.
11. Dominguez-Soto A., Sierra-Filardi E., Puig-Kroger A., Perez-Maceda B., Gomez-Aguado F., Corcuera M.T., Sanchez-Mateos P., Corbi A.L. Dendritic cell-specific ICAM-3-grabbing nonintegrin expression on M2-polarized and tumor-associated macrophages is macrophage-CSF dependent and enhanced by tumor-derived IL-6 and IL-10. J. Immunol. 2011, 186:2192-2200.
12. Donaldson M.S. Nutrition and cancer: a review of the evidence for an anti-cancer diet. Nutr. J. 2004, 3:19.
13. FAO/WHO Evaluation of Health and Nutritional Properties of Powder Milk and Live Lactic Acid Bacteria 2001, Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report, Available from http://www.fao.org/ag/agn/agns/micro_probiotics_en.asp.
14. Feghali C.A., Wright T.M. Cytokines in acute and chronic inflammation. Front. Biosci. 1997, 2:d12-d26.
15. Fu Z., Zuo Y., Li D., Xu W., Chen H., Zheng S. The crosstalk: tumor-infiltrating lymphocytes rich in regulatory T cells suppressed cancer-associated fibroblasts. Acta Oncol. 2013, 52:1760-1770.
16. Galdeano C.M., Perdigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J. Appl. Microbiol. 2004, 97:673-681.
17. Galdeano C.M., Perdigon G. The probiotic bacterium Lactobacillus casei induces activation of the gut mucosal immune system through innate immunity. Clin. Vacc. Immunol. 2006, 13:219-226.
18. Galdeano C.M., de Moreno de LeBlanc A., Vinderola G., Bonet M.E., Perdigon G. Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin. Vacc. Immunol. 2007, 14:485-492.
19. Gaon D., Garcia H., Winter L., Rodriguez N., Quintas R., Gonzalez S.N., Oliver G. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina (Buenos Aires) 2003, 63:293-298.
20. Geng Y., Chandrasekaran S., Hsu J.W., Gidwani M., Hughes A.D., King M.R. Phenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesion. PLOS ONE 2013, 8:e54959.
21. Ghosh S., Ashcraft K. An IL-6 link between obesity and cancer. Front. Biosci. (Elite Ed.) 2013, 5:461-478.
22. Jirillo E., Jirillo F., Magrone T. Healthy effects exerted by prebiotics, probiotics, and symbiotics with special reference to their impact on the immune system. Int. J. Vitam. Nutr. Res. 2012, 82:200-208.
23. Jung M., Weigert A., Tausendschon M., Mora J., Oren B., Sola A., Hotter G., Muta T., Brune B. Interleukin-10-induced neutrophil gelatinase-associated lipocalin production in macrophages with consequences for tumor growth. Mol. Cell. Biol. 2012, 32:3938-3948.
24. Kato I. Antitumor activity of lactic acid bacteria. Probiotics 3: Immunomodulation by the Gut Microflora and Probiotics 2000, 115-138. Kluwer Academic Publishers, London. R. Fuller, G. Perdigon (Eds.).
25. Kumar M., Kumar A., Nagpal R., Mohania D., Behare P., Verma V., Kumar P., Poddar D., Aggarwal P.K., Henry C.J., Jain S., Yadav H. Cancer-preventing attributes of probiotics: an update. Int. J. Food Sci. Nutr. 2010, 61:473-496.
26. Le M.G., Moulton L.H., Hill C., Kramar A. Consumption of dairy produce and alcohol in a case-control study of breast cancer. J. Natl. Cancer Inst. 1986, 77:633-636.
27. LeBlanc J.G., Matar C., Valdez J.C., LeBlanc J., Perdigon G. Immunomodulating effects of peptidic fractions issued from milk fermented with Lactobacillus helveticus. J. Dairy Sci. 2002, 85:2733-2742.
28. Lewis C.E., Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 2006, 66:605-612.
29. Maroof H., Hassan Z.M., Mobarez A.M., Mohamadabadi M.A. Lactobacillus acidophilus could modulate the immune response against breast cancer in murine model. J. Clin. Immunol. 2012, 32:1353-1359.
30. Matar C., Valdez J.C., Medina M., Rachid M., Perdigon G. Immunomodulating effects of milks fermented by Lactobacillus helveticus and its non-proteolytic variant. J. Dairy Res. 2001, 68:601-609.
31. Moorman P.G., Terry P.D. Consumption of dairy products and the risk of breast cancer: a review of the literature. Am. J. Clin. Nutr. 2004, 80:5-14.
32. Motro B., Itin A., Sachs L., Keshet E. Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:3092-3096.
33. Nicolini A., Carpi A. Immune manipulation of advanced breast cancer: an interpretative model of the relationship between immune system and tumor cell biology. Med. Res. Rev. 2009, 29:436-471.
34. Purohit A., Newman S.P., Reed M.J. The role of cytokines in regulating estrogen synthesis: implications for the etiology of breast cancer. Breast Cancer Res. 2002, 4:65-69.
35. Rizzardini G., Eskesen D., Calder P.C., Capetti A., Jespersen L., Clerici M. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12(R) and Lactobacillus paracasei ssp. paracasei L. casei 431(R) in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br. J. Nutr. 2011, 107:876-884.
36. Sellers W.R., Fisher D.E. Apoptosis and cancer drug targeting. J. Clin. Invest. 1999, 104:1655-1661.
37. Thomssen C. Consumption of cow's milk and possible risk of breast cancer. Breast Care (Basel) 2010, 5:44-46.
38. Van Ginderachter J.A., Movahedi K., Hassanzadeh Ghassabeh G., Meerschaut S., Beschin A., Raes G., De Baetselier P. Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology 2006, 211:487-501.
39. van't Veer P., Dekker J.M., Lamers J.W., Kok F.J., Schouten E.G., Brants H.A., Sturmans F., Hermus R.J. Consumption of fermented milk products and breast cancer: a case-control study in The Netherlands. Cancer Res. 1989, 49:4020-4023.
40. Vlieger A.M., Robroch A., van Buuren S., Kiers J., Rijkers G., Benninga M.A., te Biesebeke R. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial. Br. J. Nutr. 2009, 102:869-875.
41. Yazdi M.H., Mahdavi M., Kheradmand E., Shahverdi A.R. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4T1 breast cancer bearing mice. Arzneimittelforschung 2012, 62:525-531.